Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Central disorders

It has been suggested that the central disorder of ADHD is an impairment of behavioral inhibition of responding to inappropriate external stimuli or distracters (Barkley, 1997). Children with ADHD showed excessive errors of commission and a stronger tendency to respond correctly and in error during a Continuous Performance Task (laboni et al.,... [Pg.26]

Absent ot severely impaired spontaneous Ineathing efforts Central disorders (i.e., major strokes, eentral hypoventilation)... [Pg.175]

The bulk stmcture of the catalyticaHy active phase is not completely known and is under debate in the Hterature (125,131—133). The central point of controversy is whether (Valone or in combination with other phases is the most catalyticaHy active for the conversion of butane to maleic anhydride. The heart of this issue concerns the role of stmctural disorder in the bulk and how it arises in the catalyst (125,134,135). Most researchers agree that the catalysts with the highest activity and selectivity ate composed mainly of (Vthat exhibits a clustered or distorted platelet morphology (125). It is also generaHy acknowledged that during operation of the catalyst, the bulk oxidation state of the vanadium in the catalyst remains very close to the +4 valence state (125). [Pg.454]

CCK is found in the digestive tract and the central and peripheral nervous systems. In the brain, CCK coexists with DA. In the peripheral nervous system, the two principal physiological actions of CCK are stimulation of gaU. bladder contraction and pancreatic enzyme secretion. CCK also stimulates glucose and amino acid transport, protein and DNA synthesis, and pancreatic hormone secretion. In the CNS, CCK induces hypothermia, analgesia, hyperglycemia, stimulation of pituitary hormone release, and a decrease in exploratory behavior. The CCK family of neuropeptides has been impHcated in anxiety and panic disorders, psychoses, satiety, and gastric acid and pancreatic enzyme secretions. [Pg.539]

The ACGIH recommended maximum time-weighted average concentration in the workplace atmosphere for eight-hour daily exposure is 10 ppm. OSHA has set the permissible exposure level at 2 ppm. It maybe desirable to exclude alcohoHcs, persons with chronic disorders of the Hver, kidneys, and central nervous system, and those with nutritional deficiencies from working with chloroform. [Pg.527]

The effects of occupational exposure to lindane have been investigated extensively (96—100). These studies indicated that occupational exposure to lindane resulted in increased body burdens of this chemical however, toxic effects associated with these exposures were minimal and no central nervous system disorders were observed. This is in contrast to the polyneuropathies that are often observed after exposure to other haloorganic solvents. [Pg.68]

Little attempt has been made to develop drugs targeted specifically to white adipose tissue and the production of adipokines. It is likely, however, that there will be an increasing emphasis on this approach to the pharmacological treatment of obesity-related diseases, given the current views on the centrality of the adipokines to these disorders. It is, of course, the diseases that obesity leads to, rather than obesity itself, that constitute the main medical challenge. [Pg.40]

In central diabetes insipidus a hypophysial malfunction, caused by different diseases as well as head injuries, neurosurgery, or genetic disorders, leads to AVP hyposecretion. This type of diabetes insipidus can successfully be treated by the exogenous administration of AVP or AVP analogues (e.g. desmopressin). [Pg.346]

Reye syndrome is a rare disorder in children, characterized by a combination of severe liver disorder and encephalopathy (central nervous system (CNS) disturbances) that can follow an acute viral illness and which has a relatively high mortality. It has been found to be... [Pg.1079]

Preanesthetic drugs may be omitted in those 60 years or older because many of the medical disorders for which these drugsare contraindicated are seen in older individuals For example, atropine and glycopyrrolate, drugs that can be used to decrease secretions of the upper respiratory tract, are contraindicated in certain medical disorders such as prostatic hypertrophy, glaucoma, and myocardial ischemia. Other preanesthetic drugs that depress the central nervous astern (CN, such as narcotics barbiturates and antianxiety drugs with or without antiemetic properties may be contraindicated in the older individual. [Pg.319]

OB Nonzero entropy at T = 0 indicates disorder. This disorder results when a molecule can orient itself more than one way in the crystal. In ice, each O atom is surrounded by four H atoms, of which there are two types. Two of the H atoms are covalently bonded to the O atom and the other two H atoms, which belong to neighboring water molecules, are interacting with the central O atom through hydrogen bonds. Thus, more than one orientation is possible in the crystal and entropy will nor be zero at T = 0. [Pg.975]

Diseases affecting skeletal muscle are not always primary diseases of muscle, and it is necessary first to determine whether a particular disorder is a primary disease of muscle, is neurogenic in origin, is an inflammatory disorder, or results from vascular insufficiency. A primary disease of muscle is one in which the skeletal muscle fibers are the primary target of the disease. Neurogenic disorders are those in which weakness, atrophy, or abnormal activity arises as a result of pathological processes in the peripheral or central nervous system. Inflammatory disorders may result in T-cell mediated muscle damage and are often associated with viral infections. Vascular insufficiency as a result of occlusion in any part of the muscle vasculature can cause severe disorders of muscle, especially in terms of pain, metabolic insufficiency, and weakness. [Pg.282]


See other pages where Central disorders is mentioned: [Pg.689]    [Pg.689]    [Pg.200]    [Pg.498]    [Pg.541]    [Pg.217]    [Pg.218]    [Pg.237]    [Pg.465]    [Pg.33]    [Pg.110]    [Pg.359]    [Pg.359]    [Pg.234]    [Pg.100]    [Pg.102]    [Pg.174]    [Pg.403]    [Pg.368]    [Pg.7]    [Pg.294]    [Pg.55]    [Pg.145]    [Pg.181]    [Pg.193]    [Pg.590]    [Pg.755]    [Pg.795]    [Pg.798]    [Pg.798]    [Pg.823]    [Pg.831]    [Pg.1125]    [Pg.1297]    [Pg.173]    [Pg.174]    [Pg.102]    [Pg.254]    [Pg.264]    [Pg.311]   
See also in sourсe #XX -- [ Pg.190 , Pg.717 ]




SEARCH



Benzodiazepines central nervous system disorders

Central nervous system disorders

Central nervous system disorders anxiety

Central nervous system disorders attention deficit hyperactivity disorder

Central nervous system disorders brain physiology

Central nervous system disorders dementia

Central nervous system disorders depression

Central nervous system disorders epilepsy

Central nervous system disorders insomnia

Central nervous system disorders mania

Central nervous system disorders neurotransmitters

Central nervous system disorders psychoses

Central nervous system disorders schizophrenia

Central nervous system stimulants disorder

Dopamine central nervous system disorders

Hormones central nervous system disorders

© 2024 chempedia.info